Related Experiment Video

Updated: Aug 29, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

The chimeric CYP21P/CYP21 gene and 21-hydroxylase deficiency

Hsien-Hsiung Lee1

  • 1King Car Food Industrial Co., Yuan-Shan Research Institute, 326 Yuan-Shan Road, Sec. 2, Yuanshan, 264, Ilan, Taiwan, Republic of China. hhlee@ms2.kingcar.com.tw.

Journal of Human Genetics
|January 20, 2004
PubMed

Insights

Chimeric CYP21P/CYP21 genes, a cause of congenital adrenal hyperplasia (CAH), result from deletions. These complex gene rearrangements are difficult to detect using standard methods.

Area of Science:

  • Genetics
  • Molecular Biology
  • Endocrinology

Background:

  • Congenital adrenal hyperplasia (CAH) is often caused by steroid 21-hydroxylase deficiency, linked to the CYP21 gene.
  • Chimeric CYP21P/CYP21 genes arise from deletions within the C4-CYP21 repeat module, leading to altered gene structures.
  • Three distinct chimeric gene variants have been identified in ethnic Chinese CAH patients.

Purpose of the Study:

  • To investigate the genetic basis of specific chimeric CYP21P/CYP21 gene structures in CAH.
  • To understand the mechanisms of chimera formation and their impact on CYP21 gene function.
  • To develop reliable methods for detecting these complex genetic alterations.

Main Methods:

  • Analysis of gene deletions and chimeric gene formation in CAH patients.
  • Investigating the role of chi-like sequences and minisatellite consensus in chimera initiation.
  • Utilizing PCR amplification with allele-specific primers and Southern blot analysis with specific enzyme digestion (Ase I, Nde I).

Main Results:

  • Chimeric CYP21P/CYP21 genes are formed by significant deletions (26- or 32-kb) in the C4-CYP21 repeat module.
  • These chimeras share a common 5' end from CYP21P but vary in their 3' CYP21 gene sequences.
  • Conventional PCR methods fail to detect these chimeras due to issues like allele dropout caused by Taq I digestion fragments.

Conclusions:

  • The chimeric CYP21P/CYP21 gene is a significant cause of CAH and presents diagnostic challenges.
  • A combined approach of allele-specific PCR and Southern blot analysis is effective for identifying these chimeric genes.
  • Further research is needed to fully elucidate the initiation mechanisms and clinical implications of these genetic variations.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Karyotyping01:17

Karyotyping

Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...
Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...